Bayer Group Key Data

 

 

Q1 2016

 

Q1 2017

 

Change

 

Full Year 2016

 

 

€ million

 

€ million

 

%

 

€ million

2016 figures restated

1

For definition see Annual Report 2016, Chapter “Alternative Performance Measures Used by the Bayer Group.”

2

Employees calculated as full-time equivalents (FTEs)

Sales

 

11,854

 

13,244

 

+11.7

 

46,769

Change (adjusted for currency and portfolio effects)1

 

 

 

 

 

+9.4

 

+3.5%

Change in sales1

 

 

 

 

 

 

 

 

Volume

 

+5.2%

 

+5.9%

 

 

 

+4.2%

Price

 

−2.0%

 

+3.5%

 

 

 

−0.7%

Currency

 

−2.8%

 

+2.3%

 

 

 

−2.0%

Portfolio

 

+0.1%

 

0.0%

 

 

 

0.0%

EBITDA1

 

3,359

 

3,846

 

+14.5

 

10,785

Special items1

 

(28)

 

(47)

 

 

 

(517)

EBITDA before special items1

 

3,387

 

3,893

 

+14.9

 

11,302

EBITDA margin before special items1

 

28.6%

 

29.4%

 

 

 

24.2%

EBIT1

 

2,320

 

3,116

 

+34.3

 

7,042

Special items1

 

(272)

 

(85)

 

 

 

(1,088)

EBIT before special items1

 

2,592

 

3,201

 

+23.5

 

8,130

Financial result

 

(315)

 

(349)

 

−10.8

 

(1,155)

Net income (from continuing and discontinued operations)

 

1,511

 

2,083

 

+37.9

 

4,531

Earnings per share (from continuing and discontinued operations) (€)1

 

1.83

 

2.39

 

+30.6

 

5.44

Core earnings per share (from continuing operations) (€)1

 

2.35

 

2.62

 

+11.5

 

7.32

Net cash provided by operating activities (from continuing and discontinued operations)

 

1,322

 

841

 

−36.4

 

9,089

Cash outflows for capital expenditures

 

363

 

415

 

+14.3

 

2,578

Research and development expenses

 

1,109

 

1,158

 

+4.4

 

4,666

Depreciation, amortization and impairments

 

1,039

 

730

 

−29.7

 

3,743

Number of employees at end of period2

 

116,225

 

115,578

 

−0.6

 

115,200

Personnel expenses (including pension expenses)

 

2,832

 

3,124

 

+10.3

 

11,357